BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25612652)

  • 21. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
    Li W; Sciallis A; Lew M; Pang J; Jing X
    Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE; Mirocha J; Bose S
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
    Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'.
    Olson MT; Clark DP; Erozan YS; Ali SZ
    Acta Cytol; 2011; 55(6):518-25. PubMed ID: 22156460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation.
    Huhtamella R; Kholová I
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Lymphocytic Thyroiditis May Lower Accuracy of AUS/FLUS Cytopathology in Surgical Patients.
    Mulder MB; Khazeni KC; Sussman MS; Lew JI; Farrá JC
    J Surg Res; 2020 Jan; 245():244-248. PubMed ID: 31421369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
    Chen YH; Partyka KL; Dougherty R; Cramer HM; Wu HH
    Diagn Cytopathol; 2020 Dec; 48(12):1237-1243. PubMed ID: 32716614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
    Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of 'The Bethesda System for reporting Thyroid Cytopathology': A MultiCenter Study with Review of the Literature.
    Bhasin TS; Mannan R; Manjari M; Mehra M; Gill Sekhon AK; Chandey M; Sharma S; Kaur P
    J Clin Diagn Res; 2013 Jun; 7(6):1051-4. PubMed ID: 23905101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
    Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
    Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system.
    Ustün H; Astarcı HM; Altunkaya C; Yılmaz S; Barın A; Ekici S; Caydere M
    Acta Cytol; 2012; 56(4):361-9. PubMed ID: 22846585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
    Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
    Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations.
    Ohori NP; Schoedel KE
    Acta Cytol; 2011; 55(6):492-8. PubMed ID: 22156456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
    Singh RS; Wang HH
    Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases.
    Smith M; Pantanowitz L; Khalbuss WE; Benkovich VA; Monaco SE
    Acta Cytol; 2013; 57(4):341-8. PubMed ID: 23859872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
    Wu HH; Rose C; Elsheikh TM
    Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
    Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
    Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.